Cargando…
Peptide Nanofiber System for Sustained Delivery of Anti-VEGF Proteins to the Eye Vitreous
Ranibizumab is a recombinant VEGF-A antibody used to treat the wet form of age-related macular degeneration. It is intravitreally administered to ocular compartments, and the treatment requires frequent injections, which may cause complications and patient discomfort. To reduce the number of injecti...
Autores principales: | Yaylaci, Seher, Dinç, Erdem, Aydın, Bahri, Tekinay, Ayse B., Guler, Mustafa O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141348/ https://www.ncbi.nlm.nih.gov/pubmed/37111749 http://dx.doi.org/10.3390/pharmaceutics15041264 |
Ejemplares similares
-
Sulfated GAG mimetic peptide nanofibers enhance chondrogenic differentiation of mesenchymal stem cells in 3D in vitro models
por: Yaylaci, Seher, et al.
Publicado: (2022) -
Microporous Drug Delivery System for Sustained Anti-VEGF Delivery to the Eye
por: Zhou, Chengxin, et al.
Publicado: (2020) -
Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy
por: Eraslan, Seher, et al.
Publicado: (2020) -
Basal Lamina Mimetic Nanofibrous Peptide Networks for Skeletal Myogenesis
por: Yasa, I. Ceren, et al.
Publicado: (2015) -
Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma
por: Ucan Gunduz, Gamze, et al.
Publicado: (2019)